Abstract

Variations on the statement “the variant surface glycoprotein (VSG) coat that covers the external face of the mammalian bloodstream form of Trypanosoma brucei acts a physical barrier” appear regularly in research articles and reviews. The concept of the impenetrable VSG coat is an attractive one, as it provides a clear model for understanding how a trypanosome population persists; each successive VSG protects the plasma membrane and is immunologically distinct from previous VSGs. What is the evidence that the VSG coat is an impenetrable barrier, and how do antibodies and other extracellular proteins interact with it? In this review, the nature of the extracellular surface of the bloodstream form trypanosome is described, and past experiments that investigated binding of antibodies and lectins to trypanosomes are analysed using knowledge of VSG sequence and structure that was unavailable when the experiments were performed. Epitopes for some VSG monoclonal antibodies are mapped as far as possible from previous experimental data, onto models of VSG structures. The binding of lectins to some, but not to other, VSGs is revisited with more recent knowledge of the location and nature of N-linked oligosaccharides. The conclusions are: (i) Much of the variation observed in earlier experiments can be explained by the identity of the individual VSGs. (ii) Much of an individual VSG is accessible to antibodies, and the barrier that prevents access to the cell surface is probably at the base of the VSG N-terminal domain, approximately 5 nm from the plasma membrane. This second conclusion highlights a gap in our understanding of how the VSG coat works, as several plasma membrane proteins with large extracellular domains are very unlikely to be hidden from host antibodies by VSG.

Highlights

  • African trypanosomes have evolved two key strategies to prevent killing by the host immune response and, maintain a long-term infection in a mammal

  • The sequences of one Con A binding variant surface glycoprotein (VSG) (BoTat 78) and one non-binding VSG (BoTat 1) have subsequently become available, and the location of N-linked glycosylation sites in these two VSGs provides an explanation for the difference: one site in VSG BoTat 1 is in the C-terminal domain; the other is at the base of the N-terminal domain

  • One important question to be answered is how far extracellular macromolecules can penetrate into the VSG coat

Read more

Summary

Introduction

African trypanosomes have evolved two key strategies to prevent killing by the host immune response and, maintain a long-term infection in a mammal. The size of a VSG dimer can be derived from the structure of the N-terminal domain [5,9], and it is assumed that the long axis is perpendicular to the plasma membrane surface (Fig 1).

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call